![Chien Chung Chen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Chien Chung Chen
Director of Finance/CFO at Vita Genomics, Inc.
Profile
Chien Chung Chen is currently the Chief Financial Officer at Vita Genomics, Inc. Previously, he worked as an Independent Director at Kuangli Bio-Tech Holdings Co. Ltd.
Chen received his undergraduate degree from Soochow University.
Chien Chung Chen active positions
Companies | Position | Start |
---|---|---|
Vita Genomics, Inc.
![]() Vita Genomics, Inc. Medical/Nursing ServicesHealth Services Vita Genomics, Inc. provides drug research services. It operates as a genomics-based biotechnological and biopharmaceutical company. The firm focuses on conducting pharmacogenomics research, in vitro diagnosis product development, and specialty contract research services in both genomics and pharmacogenomics fields. It offers advanced molecular diagnostic products and services, revolutionizing the drug-development process and providing pharmacogenomic solutions. The company was founded in March 2001 and is headquartered in New Taipei City, Taiwan. | Director of Finance/CFO | - |
Former positions of Chien Chung Chen
Companies | Position | End |
---|---|---|
KUANGLI BIO-TECH HOLDINGS CO., LTD. | Director/Board Member | - |
Training of Chien Chung Chen
Soochow University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
KUANGLI BIO-TECH HOLDINGS CO., LTD. | Electronic Technology |
Private companies | 1 |
---|---|
Vita Genomics, Inc.
![]() Vita Genomics, Inc. Medical/Nursing ServicesHealth Services Vita Genomics, Inc. provides drug research services. It operates as a genomics-based biotechnological and biopharmaceutical company. The firm focuses on conducting pharmacogenomics research, in vitro diagnosis product development, and specialty contract research services in both genomics and pharmacogenomics fields. It offers advanced molecular diagnostic products and services, revolutionizing the drug-development process and providing pharmacogenomic solutions. The company was founded in March 2001 and is headquartered in New Taipei City, Taiwan. | Health Services |
- Stock Market
- Insiders
- Chien Chung Chen